Skip to main content
. 2022 Dec 8;13:1072351. doi: 10.3389/fneur.2022.1072351

Table 4.

Factors in correlation with 6-month poor prognosis following aneurysmal subarachnoid hemorrhage.

Poor prognosis Good prognosis P-value
Male 42 (42.9%) 71 (44.7%) 0.778
Age (years) 52.0 ± 11.1 50.6 ± 10.2 0.334
Cigarette smoking 32 (32.7%) 51 (32.1%) 0.923
Alcohol drinking 29 (29.6%) 37 (23.3%) 0.260
Hypertension 24 (24.5%) 29 (18.2%) 0.229
Diabetes mellitus 15 (15.3%) 8 (5.0%) 0.005
Hyperlipidemia 18 (18.4%) 20 (12.6%) 0.204
Previous use of statins 7 (7.1%) 14 (8.8%) 0.637
Previous use of anticoagulation drugs 9 (9.2%) 4 (2.5%) 0.018
Previous use of antiplatelet drugs 6 (6.1%) 6 (3.8%) 0.386
Hunt-Hess scores 4 (3–4) 2 (2–3) < 0.001
Modified Fisher scores 3 (2–3) 2 (1–2) < 0.001
Aneurysms located at anterior circulation 80 (81.6%) 127 (79.9%) 0.729
Cystic aneurysms 83 (84.7%) 132 (83.0%) 0.724
Aneurysms with diameter of < 10 mm 53 (54.1%) 100 (62.9%) 0.162
Surgical clipping for securing aneurysms 33 (33.7%) 63 (39.6%) 0.338
Acute hydrocephalus 23 (23.5%) 9 (5.7%) < 0.001
Intraventricular hemorrhage 15 (15.3%) 11 (6.9%) 0.030
External ventricular drain 17 (17.3%) 16 (10.1%) 0.090
Admission time after stroke (h) 10.1 (4.6–14.2) 10.3 (5.1–14.7) 0.729
Blood-collection time after stroke (h) 11.8 (6.7–16.0) 11.6 (6.5–16.6) 0.975
Blood glucose levels (mmol/L) 12.7 (8.8–17.3) 10.3 (8.6–12.0) < 0.001
Blood leukocyte count ( × 109/L) 7.8 (6.5–10.4) 7.5 (5.9–11.3) 0.963
Serum HIF-1α levels > 384.0 pg/ml 70 (71.4%) 30 (18.9%) < 0.001

Variables were reported as count (proportion), mean ± standard deviation, or median (percentiles 25th−75th) where appropriate. Statistical methods included the student t-test, Mann–Whitney test, Fisher's exact test, and χ2 test. HIF-1α means hypoxia-inducible factor 1alpha. Poor outcome was defined as extended Glasgow outcome scale scores of 1–4.